Kenvue CEO Mongon stepping down as company continues with strategic review

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company Kenvue used to be a part of Johnson Johnson J J informed in late that it was splitting its consumer medical division from the pharmaceutical and physiological device divisions in a bid to make each more nimble Kenvue revealed Monday that board member Kirk Perry will serve as interim CEO effective instantly Perry has served as a director since December and preponderance in the last few days served as CEO of Circana a provider of arena research He spent more than years at Procter Gamble in various roles Kenvue also mentioned that it is continuing to work with its strategic review committee to explore options for the company The Board s strategic review is underway and we are considering a broad range of prospective alternatives including strategies to simplify the Company s portfolio and how it operates Chair Larry Merlo revealed in a comment Kenvue provided several preliminary results for its fiscal second quarter The company anticipates adjusted earnings in a range of cents to cents per share Analysts polled by FactSet expect earnings of cents per share Kenvue will record its full quarterly results on Aug and explained that it will revise its full-year outlook on that date Shares rose more than before the region open Source